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Abstract
 
The intention of the current study was to gain more insight into the endocrine and molecular control mechanisms of
growth in the pig. For this purpose various growth related parameters were determined in 4-month-old barrows of
two extreme pig genotyes, the small, obese Göttingen Miniature (GM) and the large and lean German Landrace
(DL). Mean growth hormone (GH) concentration, GH pulse frequency and GH pulse amplitude did not differ
between breeds. Likewise, plasma IGF-1, thyroxine, tri-iodothyronine (T
 
3
 
) concentrations were similar in both
breeds. However the plasma GH response (maximum level and area under curve) to a single i.v.
 
 
 
injection of GHRH
in DL was higher than in GM (
 
P 
 
< 0·05). Furthermore, basal plasma insulin and in particular plasma cortisol
concentrations were higher in GM compared with DL pigs (
 
P 
 
< 0·05 and <0·01 respectively). Analysis of cortisol
during 4-h frequent blood sampling indicated higher cortisol amplitudes in GM compared with DL (
 
P
 
 
 
≤
 
 0·01).
Speciﬁc bGH-binding to hepatic membrane preparations was not different between breeds and IGF-1  m RNA
concentrations determined by reverse transcription-polymerase chain reaction in liver, 
 
m. semimenbranosus
 
 and
 
m. longissimus dorsi
 
 were similar in both breeds. I.m. treatment with recombinant porcine somatotropin (rpST;
70 
 
µ
 
g/kg live weight) over an 8-day period in contemporary barrows increased without any breed difference, plasma
IGF-1, T
 
3
 
 and insulin concentrations and hepatic speciﬁc bGH-binding, but did not affect thyroxine or cortisol
concentrations in plasma. IGF-1 gene expression was also elevated in liver and muscle tissues in rpST-treated
animals without obvious breed effects. The observations underline the complexity of the hormonal and molecular
control of growth and support the notion that differences in growth potential are the consequence of differences at
various levels of the somatotropic axis and apparently relate to differences in other control systems of energy
metabolism such as the pituitary adrenal axis or the endocrine pancreas as well. 
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Introduction
 
Undoubtedly the principal hormone involved in
stimulating growth in the pig as in other species is
pituitary growth hormone (GH). Hypophysectomy
arrests somatic growth in the pig, an effect which can
be transiently overcome by exogenous GH
(Anderson 
 
et al.,
 
 1981). The growth promoting and
anabolic actions of GH are mediated by insulin like
growth factors (IGF-1 and IGF-2) acting in both an 
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endocrine and paracrine manner. During postnatal
growth genetically lean and obese, small and large,
fast and slow growing pigs do not necessarily differ
in their plasma concentrations of GH (Arbona 
 
et al.,
 
1988; Buonomo and Klindt, 1993; Clutter 
 
et al.,
 
 1995)
nor that of IGF-1 (Zenobi 
 
et al.,
 
 1988; Owens 
 
et al.,
 
1999). However, pigs selected for fast gain expressed
greater concentrations of circulating IGF-I than their
contemporaries selected for slow gain (Clutter 
 
et al.,
 
1995). 
Responsiveness of target tissues may be another
factor determining differences in growth potential.
For example, the expression of the GH receptor
(GHR) in liver and muscles or the response of IGF-1
in these tissues may differ between pig breeds with
divergent growth potential. No differences in the
expression of the GHR gene were observed between
pig breeds with varying growth characteristics, but
the observed differences in muscle and adipose
tissue IGF-1 expression may relate to the overall
growth of the animal (Bramfeld 
 
et al.,
 
 1996a). 
Weiler 
 
et al. 
 
(1998) in their publication stressed the
importance of catabolic hormones like cortisol to
explain differences in growth potential. According to
their data the slow growing wild boar and the
Meishan breed displayed higher plasma cortisol
concentrations than the fast-growing Large White
breed, while the plasma concentrations of IGF-1 and
GH in the wild boar were higher than in the Large
White breed. 
The intention of the present study was to gain more
insight into the endocrine and molecular control
mechanisms of growth in the pig by determining
various growth related parameters. Our
experimental approach was the comparison of two
extreme genotypes, which differ markedly in their
growth potential: The Göttingen Miniature (GM) pig,
a small, obese breed and the German Landrace (DL)
pig, a conventional breed selected for lean meat
production. In these breeds we determined the
plasma concentrations of various anabolic and
catabolic hormones. Furthermore the concentrations
of GHR in the liver and that of IGF-1 mRNA in liver
and two types of muscles were measured. In
addition the responses of these parameters to a
growth hormone treatment (recombinant porcine
somatotropin; rpST) were compared. 
 
Material and methods
 
Animals, treatments and blood sampling
 
Barrows of the German Landrace (Deutsche
Landrasse, DL, no.  =  17) and Göttingen Miniature
breeds (GM, no. = 16) from the Institut für Tierzucht
und Tierverhalten (FAL) experimental farm were
used in this study at 4 months of age (range 12 days).
Mean body weight at this age for DL and GM was 58
(s.e.
 
 
 
1·9)  kg and 24 (s.e.
 
 
 
0·8)  kg, respectively. The
animals were kept individually in animal crates in a
purpose-built environmentally controlled building
under constant temperature (20ºto 22ºC). The
animals were given food to appetite twice daily.
Three to 4 days before the ﬁrst blood sample was
taken animals were ﬁtted surgically with an
indwelling jugular catheter. At 08:00  h seven DL
barrows and six GM barrows received i.m. injections
of 70 µg rpST per kg body weight for 9 days while all
other animals received vehicle treatment. rpST was a
kind donation by Pitman Moore, USA and was
dissolved in carbonate buffer, pH 9·98 (25  mmol/l
NaHCO
 
3
 
, 25 mmol/l Na
 
2
 
CO
 
3
 
). Daily blood samples
(5 ml) were taken at 11:00 h starting 1 day before ﬁrst
treatment with rpST (day 0) until day 9 of treatment.
On day 6 of treatment additional blood samples
(2·5  ml) were collected at 15-min intervals from
08:30 h to 12:30 h for determination of GH secretion
proﬁles. At 12:30 h control animals were treated i.v.
with 7 µg GHRH (Bissendorf Biochemicals/Bachem,
Germany) per kg body weight and blood samples
were taken 5, 10, 15, 20, 30, 60, 90, 120, 150 and 180
min after GHRH. Heparinized samples were kept on
ice and centrifuged within 3 h of collection. Plasma
was split into two to three aliquots and stored at
–20ºC until analysis. 
On day 9 at 06:00 h animals were given one-third of
their normal ration and at 08:00 h received rpST or
vehicle treatment as before. Starting at 09:00 h control
and rpST treated animals were slaughtered in
alternate order and standard parameters for carcass
evaluation were taken. Tissue samples (two 3 to 5 g,
two 1  g) from liver, 
 
m. longissimus dorsi
 
 and 
 
m.
semimembranosus
 
 were collected within 15 min after
slaughter, sealed in aluminium bags and frozen in
liquid nitrogen and stored at –70ºC until analysis of
GH receptor and IGF-1 mRNA. 
 
Hormone analysis
 
Plasma GH levels were determined by a competitive
enzyme immunoassay as described previously by
Serpek 
 
et al. 
 
(1993) using a rabbit anti pGH antiserum
raised by ourselves (K 37 . . .), biotinyl-pGH as a
tracer and streptavidin–horseradish peroxidase. The
assay has 50% crossreaction with rpST. Intra- and
inter-assay variation was 0·11 and 0·16, respectively
Plasma IGF-1 levels were determined by
radioimmunoassay after acid ethanol
cryoprecipitation as described by Breier 
 
et al. 
 
(1993).
The antiserum used has 0·5% crossreactivity with
IGF-2 and less than 0·001% with insulin. IGF-1 was
labelled by the chloramine-T-method to speciﬁc 
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Figure 1 Plasma GH concentrations (mean ±  s.e.) in
Göttingen Miniature (GM) and German Landrace (DL) pigs.
(a) Daily blood samples taken over the treatment period.
Animals received once daily i.m. 70 µ g rpST per kg body
weight (circles) or received vehicle treatment (triangles).
Closed symbols: GM, open symbols: DL. (b) Frequent blood
samples taken from pigs not treated with rpST, before and
after a single i.v. injection of 7 µ g GHRH per kg body
weight. Closed triangles: GM, open triangles: DL.
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activities between 40 and 60 
 
µ
 
 Ci/
 
µ
 
g. Recombinant
hIGF-1 (batch 87/518, National Institute for
Biological Standards and Controls, Potters Bar,
Hertfordshire, UK) was used to standardize a plasma
pool which was then used as standard preparation.
Intra- and inter-assay variation was 0·10 and 0·14
respectively. 
Plasma levels of insulin, thyroxine (T
 
4
 
) and tri-
iodothyronine (T
 
3
 
) were determined using
commercially established 
 
125
 
I-RIA kits from Behring,
Germany (RIA-gnost
 

 
 Insulin, RIA-gnost
 

 
 T
 
4
 
 and
RIA-gnost
 

 
 T
 
3
 
, respectively) following the
instructions of the manufacturer. For the
determination of insulin and T
 
3, 
 
100 µl plasma were
used, 20 µl plasma were used for the determination
of T
 
4
 
. 
Plasma cortisol levels were determined by a rapid
direct EIA as recently described (Marc 
 
et al.,
 
 2000).
The method had been evaluated for direct
determination in 20 µl plasma diluted 1 : 40 without
prior extraction. The intra- and inter-assay coefﬁcient
of variation was 0·09 and 0·13, respectively. 
 
Hepatic growth hormone receptor 
 
(
 
GHR
 
)
Liver samples were processed in the presence of a
proteinase inhibitor. The homogenate was treated
with 4  mol/l MgCl
 
2
 
 in order to dissociate and to
remove endogenous pGH from the GHR. For the
determination of pGHR in the obtained crude
membrane preparations, a modiﬁed radio receptor
assay following the protocol of Sauerwein 
 
et al.
 
(1991) was performed. Using 
 
125
 
I-labelled bovine GH
in GHR measurements for porcine liver membranes
yields higher speciﬁc binding rates compared with
 
125
 
I-pGH. Therefore recombinant bGH (rbGH, Eli
Lilly, Indianapolis, USA; lot A18-7DT-170B) was used
both as unlabelled ligand for displacement studies as
well as tracer after iodination by the iodogen
method. Equilibrium was reached within 22  h at
room temperature; the binding observed was fully
reversible by the addition of excess unlabelled rbGH.
Repeated analysis of a membrane preparation pool
yielded an inter-assay variation of 0·076 (no. = 4). 
 
IGF-1 mRNA quantiﬁcation
 
Total RNA was extracted from liver and muscle
samples; 500  ng were then applied in a reverse
transcription-polymerase chain reaction (RT-PCR)
assay using an internal standard as described in
detail by Pfafﬂ 
 
et al. 
 
(1998). The assay had a detection
limit of 1600 recombinant IGF-1 RNA molecules per
reaction tube, the intra-assay variation was 0·074
(no. = 5) and linearity (
 
r = 
 
0·997) was given between
140  ng to 840  ng total-RNA input into RT-PCR
reaction. 
 
Statistics
 
Data were subjected to two-way analysis of variance
using breed and treatment as independent variables.
When treatment effects were signiﬁcant, the Student-
Newman-Keuls method was used for pairwise
multiple comparisons. The statistical procedures
were performed using Sigma Stat
 

 
 Statistical
Software (Jandel Scientiﬁc, Erkrath, Germany). Data
are expressed as means 
 
±
 
 s.e.
 
 
 
Results
 
Mean body weight in both breeds was not affected
signiﬁcantly by 9 days of treatment with rpST nor
were parameters of carcass quality. Carcass weight
for GM and DL was 17·7 (s.e.
 
 
 
1·6) and 44·3 (s.e.
 
 
 
1·5),
respectively. Lean : fat ratio (1 : 
 
x
 
) in GM was 
 
x 
 
= 0·4
(s.e.
 
 
 
0·1), for DL this ratio was 
 
x 
 
= 1·1 (s.e.
 
 
 
0·1). 
In control animals mean GH concentrations in daily
plasma samples (Figure 1a) did not differ between
breeds (1·5 (s.e.
 
 
 
0·1)  ng GH per ml plasma in both
breeds). Following daily i.m. treatment with rpST 
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Figure 2 (a) Plasma tri-iodothyronine (T3), (b) thyroxine
(T4) and (c) insulin concentrations (mean ±  s.e.) on days 2
and 7 of vehicle (control) or rpST treatment in Göttingen
Miniature (GM) and German Landrace (DL) pigs.    GM
control,    DL control,    GM rpST,    DL rpST.
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Figure 3 Plasma cortisol concentrations (mean ±  s.e.) on
days 2 and 7 of vehicle (control) or rpST treatment in
Göttingen Miniature (GM) and German Landrace (DL) pigs.
   GM control,    DL control,    GM rpST,    DL rpST.
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GH concentrations rose within 1 day and remained
constant throughout the treatment period (7·4 (s.e.
0·5) ng GH per ml plasma and 11·2 (s.e.
 
 
 
1·2) ng GH
per ml plasma in GM and DL respectively, 
 
P 
 
< 0·001
between breeds). 
During 4-h frequent sampling on day 6 mean plasma
GH concentrations (about 1·5 ng GH per ml plasma),
GH pulse frequency (about one pulse every 4 h) and
GH amplitude (about 2 ng GH per ml plasma) did
not differ between breeds in control animals.
However, the plasma GH response (maximum level
and area under the curve) to GHRH in DL was
higher than in GM with maximal GH levels in DL
pigs being about 2·5 times higher (
 
P 
 
< 0·05, Figure
1b). 
IGF-1 concentrations were not different between
breeds (291 (s.e.
 
 
 
34) and 302 (s.e.
 
 
 
26) ng IGF-1 per ml
plasma for DL and GM, respectively); rpST-treatment
led to a two-fold increase of IGF-1 plasma levels in
both breeds. Neither total plasma T
 
4 
 
nor T
 
3
 
concentration differed between breeds (Figure 2).
RpST treatment signiﬁcantly stimulated T
 
3
 
concentrations (
 
P 
 
< 0·05) without breed difference
whereas T
 
4 
 
levels were not suppressed signiﬁcantly.
Plasma insulin concentrations (Figure 2c) in GM
were slightly elevated compared with DL (
 
P 
 
< 0·05)
and were stimulated by rpST treatment (
 
P 
 
< 0·001)
without breed difference. 
Plasma cortisol concentrations were signiﬁcantly
higher in GM compared with DL (
 
P 
 
< 0·01, Figure 3).
Analysis of cortisol during 4-h frequent blood
sampling in four control GM and four contemporary
control DL barrows indicated higher cortisol pulse
amplitudes in GM compared with DL (50 (s.e.
 
 
 
6) ng
cortisol per ml 
 
v. 
 
26 (s.e.
 
 
 
3) ng cortisol per ml plasma,
respectively, 
 
P 
 
< 0·01) but no breed difference in
nadir levels (approx. 10 ng cortisol per ml plasma) or
cortisol pulse frequency (approx. one cortisol pulse
every 90 min).  
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Figure 4 IGF-1 gene expression (mean ±  s.e.) in various
tissues from Göttingen Miniature (GM) and German
Landrace (DL) pigs treated over an 8-day period with either
vehcle (control) or rpST.
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Speciﬁc bGH-binding to hepatic membrane
preparations in control animals was not different
between breeds (15·6 (s.e.
 
 
 
2·9)% in DL and 20·7 (s.e.
1·6)% in GM livers). In rpST-treated animals speciﬁc
bGH-binding was two-fold higher than in controls,
without any breed-related differences (DL: 33·6 (s.e.
3·5)%; GM: 39·4 (s.e.
 
 
 
7·3)%; 
 
P 
 
< 0·05 compared with
control). 
The amount of total RNA extractable per g tissue
was neither inﬂuenced by breed nor treatment. In
control animals, similar expression levels were
observed in liver and in the two different skeletal
muscles without any breed difference (Figure 4). In
rpST-treated pigs, IGF-1 expression was elevated in
most tissues compared with control animals
(
 
P 
 
< 0·05); in 
 
m. semimembranosus
 
 of DL and in 
 
m.
longissimus dorsi
 
 of GM animals the increase did not
reach this level of signiﬁcance (
 
P 
 
= 0·07 and 
 
P 
 
= 0·12,
respectively). Comparing liver expression rates of
rpST-treated animals, GM pigs had lower hepatic
expression levels than DL pigs; for muscles, no such
difference was observed. When considering the
mean expression rates in control animals as baseline,
rpST-treated DL pigs had 7·6-fold higher expression
rates in liver, for GM pigs the difference was only
3·6-fold. In skeletal muscle, the difference was less
pronounced; in 
 
m. semimembranosus
 
 it was 1·5-fold in
DL and 2·8 in GM; in 
 
m. longissimus dorsi
 
 it was 1·9 in
DL and 2·5 in GM, respectively. 
 
Discussion
 
The most striking difference between the two
extreme genotypes in this study is the difference in
plasma cortisol concentrations. Plasma cortisol levels
were signiﬁcantly higher in GM compared with DL.
The crucial rôle of cortisol as a key hormone of
catabolic processes in the pig has been stressed
before by Weiler 
 
et al. 
 
(1998) who found decreased
plasma cortisol concentrations in Large White pigs
compared with the European wild boar or the
Chinese Meishan boar. Apparently, selection for lean
tissue growth is even associated with a lower activity
of the HPA axis soon after birth as indicated by lower
plasma cortisol concentrations in a composite line
(highly selected for high rate of gain) compared with
the primitive Chinese Meishan breed (Herpin 
 
et al.,
 
1993). Already during foetal life cortisol enhances
adipocyte hypertrophy and concurrent action of
glucocorticoids and thyroid hormones may be the
critical aspect of endocrine regulation of foetal
adipogenesis (Hausman, 1999). In the postnatal
period cortisol has been shown to potentiate 
 
in vitro
 
the positive effect of insulin on lipogenesis in swine
adipose tissue probably by modulating insulin
receptor number and (or) other cellular proteins, e.g.
enzymes (Walton 
 
et al.,
 
 1986). Thus, the elevated
plasma cortisol concentrations in GM pigs compared
with DL may well account at least in part for the
much higher proportion of fat in the carcass of this
breed. 
The increase in plasma insulin concentrations
following rpST treatment without any breed
difference is in line with previous reports (Etherton 
 
et
al.,
 
 1986; Johnson 
 
et al.,
 
 1990). In the present study the
slow growing genotype (GM) expressed higher
insulin concentrations compared with DL. Likewise,
with the exception of Weiler 
 
et al. 
 
(1998) higher
plasma concentrations of insulin in obese pigs than
in lean pigs have been described before (Wangsness
 
et al.,
 
 1981; Mersmann 
 
et al.,
 
 1982). Studies of
Hausman (1989) demonstrate that physiological
levels of insulin can stimulate porcine pre-adipocyte
differentiation in the neonatal pig. Using older
animals, Walton and Etherton (1986) established
stimulatory effects of insulin on lipid synthesis in pig
adipose tissue 
 
in vitro
 
. Thus, in addition to elevated
plasma cortisol concentrations elevated plasma
insulin concentrations in the GM breed may be
causally related to the higher fat to lean ratio in this
breed. 
It has been suggested that thyroid hormones may
modulate the perinatal ontogeny of GH receptor
gene expression in porcine liver and muscle
(Duchamp 
 
et al.,
 
 1996). In male sheep increased
concentrations of T
 
3
 
 are correlated with increased 
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growth (Van Kessel 
 
et al.,
 
 1993) and T
 
3
 
 is more highly
correlated with serum IGF-1 and animal growth rate
than GH (Hammond 
 
et al.,
 
 1990). No such
relationship was found in this study either for T
 
4 
 
or
for the more important and bioactive T
 
3
 
. GH has
been implicated not only in the production of IGF
but also in the synthesis and metabolism of thyroid
hormones. In particular the deiodination of T
 
4
 
 to T
 
3
 
involving the action of a monodeiodinase is believed
to be controlled by GH (Jorgensen 
 
et al.,
 
 1989) which
is supported by the present ﬁndings in the pig. 
In the present study DL barrows had a higher
secretory capacity for GH than GM barrows
estimated from the concentration of GH after GHRH
challenge suggesting that in the genetically small
obese GM pig GH release is impaired. The
physiological mechanism underlying the differential
sensitivity to the same dose of GHRH is not known.
In addition to GHRH, GH secretion is under
hypothalamic control by somatostatin (SRIF) which
counteracts the effects of GHRH by inhibiting GH
release from somatotrophs. Hence the low GH
response of GM pigs to GHRH challenge may have
come about by continued inhibition of GH release
due to elevated SRIF levels compared with DL.
However, available data in the pig do not support,
indeed contradict, this notion. According to recent
own ﬁndings SRIF may not only be inhibitory to GH
secretion but may act in a paradoxically positive
manner to sensitize somatotrophs to GHRH, in
particular in GM (Elsaesser and Drath, 1995;
Torronteras 
 
et al.,
 
 1996). 
The difference in the GH response to GHRH in this
study is consistent with the hypothesis that lean and
large pigs display higher secretion rates of GH.
However, the ﬁnding of a breed difference in the
responsiveness to GHRH is difﬁcult to reconcile with
the lack of any breed difference in unstimulated GH
release and thus the differential responsiveness
observed in this study might be of no meaning to the
control of GH by endogenous GHRH in these two
breeds. The lack of any breed difference in
unstimulated GH release is in agreement with
previous reports in pigs (Arbona 
 
et al.,
 
 1988;
Buonomo and Klindt, 1993; Clutter 
 
et al.,
 
 1995). It has
even been reported that the slow growing wild boar
in comparison to a commercial pig breed like the
Large White breed displays higher plasma GH
concentrations (Weiler 
 
et al.,
 
 1998), remembering that
the function of GH is much more complex than that
of a mere growth promoter. 
In line with previous work (Sillence and Etherton,
1987) plasma IGF-1 concentrations in this study were
increased following rpST treatment. Previous studies
(Buonomo and Klindt, 1993; Clutter 
 
et al.,
 
 1995) have
demonstrated possible genetic determinants of
variation in plasma IGF-1 for pigs. However a lack of
a positive association between mature body size or
rates of gain and IGF-1 concentrations has also been
reported in pigs (Owens 
 
et al.,
 
 1990). Our data are in
accordance with a previous report from Zenobi 
 
et al.
 
(1988) demonstrating similar IGF-1 plasma
concentrations in GM and a domestic pig breed. The
conﬂicting data underline that IGF-1 is only one
factor in the complex control of growth. In agreement
with this notion the actions of pGH on growth of
pigs were not mimicked by administration of IGF-1
(Klindt 
 
et al.,
 
 1998). 
Because the ﬁrst step in GH action is binding to a
speciﬁc cell surface receptor, changes in GHR levels
may provide some insight into the importance of GH
actions. In accordance with previous ﬁndings in the
pig (Chung and Etherton, 1986; Combes 
 
et al.,
 
 1997)
the present study indicates, that irrespective of
important differences in growth rates of the two
extreme genotypes, GH treatment induces a similar
increase in GH binding to liver. Furthermore, basal
speciﬁc binding in liver was similar in both breeds
and thus cannot account for the growth differences
between GM and DL. Likewise, no difference in GH-
speciﬁc binding in liver was apparent between the
conventional Large White breed and the Chinese
Meishan breed which has a reduced rate of muscle
growth (Schnoebelen-Combes 
 
et al.,
 
 1996). 
There is still some controversy regarding the relative
importance of systemic IGF-1 derived from the liver
 
versus
 
 local IGF-1 in skeletal muscle. Earlier work in
the pig analysing IGF-1 gene expression in the 
 
m.
longissimus
 
 suggested that the stimulatory effects of
pST on muscle growth are not associated with
increased IGF-1 mRNA levels in skeletal muscle and
that IGF-1 plays an endocrine rôle in mediating GH-
induced muscle hypertrophy (Grant 
 
et al.,
 
 1991;
Coleman et al., 1994). In later studies expression of
IGF-1 mRNA was found to be GH responsive in the
liver, in adipose tissues and in the m. semitendinosus,
but in accordance with the previous work not to be
GH responsive in m. longissimus dorsi (Brameld et al.,
1996b). The present study indicates that in another
hindlimb muscle, the m. semimembranosus IGF-1 gene
expression is responsive to GH as well and that IGF-
1 in the m. longissimus dorsi might be affected by GH
too. 
The observation in some studies that GH increased
IGF-1 mRNA in liver but not in skeletal muscle or
only in distinct muscles might indicate, that the effect
of GH is tissue speciﬁc and suggests that the relative
rôles of endocrine v.  locally synthesized IGF-1 inControl of growth in two pig breeds 429
mediating the effects of GH may be tissue speciﬁc.
The ﬁndings of Brameld et al. (1996b) and the present
study describe IGF-1 responsiveness to GH in two
types of hindlimb muscles, the m. semitendinosus and
the m. semimembranosus, respectively. Brameld et al.
(1996b) suggested that the differential responsiveness
of IGF-1 expression to GH might be related to
differences in ﬁbre type between m. longissimus and
m. semitendinosus described by Ouali and Talmant
(1990), or related to differences in the muscle
responsiveness to GH as regards increasing muscle
ﬁbre area (Ono et al., 1995). However, this notion
might not hold true for all breeds and/or ages since
in the present study GH increased IGF-1 mRNA in
m. longissimus dorsi as well and Lewis et al. (2000),
although using a very high dose of GH also
demonstrated increased IGF-1 mRNA in m.
longissimus of the neonatal pig following GH
treatment. 
The present study describes in two extreme pig
genotypes a broad array of hormonal parameters
related to the control of the polygenic trait of growth
in the pig. The observations underline the
complexity of the hormonal and molecular control of
growth and support the notion that differences in
growth potential are the consequence of differences
at various levels of the somatotropic axis and
apparently relate to differences in other control
systems of energy metabolism such as the pituitary
adrenal axis, or insulin as well. 
Acknowledgements
We are grateful to Pitman-Moore for providing rpST and Dr
M. Henning for carcass classiﬁcation and help with tissue
sample collection. We appreciate the excellent technical
assistance of P. Aldag, U. Buntrock and R. Ronge. 
References
Anderson, L. L., Bohnker, C. R., Parker, R. O. and Kertiles,
L. P. 1981. Metabolic actions of growth hormone in pigs.
Journal of Animal Science 53: 363-370. 
Arbona, J. R., Marple, D. N., Russell, R. W., Rahe, C. H.,
Mulvaney, D. R. and Sartin, J. L. 1988. Secretory pattern
and metabolic clearance rate of porcine growth hormone in
swine selected for growth. Journal of Animal Science  66:
3068-3072. 
Brameld, J. M., Atkinson, J. L., Budd, T. J., Saunders, J. C.,
Pell, J. M., Salter, A. M., Gilmour, R. S. and Buttery, P. J.
1996a. Expression of insulin-like growth factor-1 (IGF-1)
and growth hormone-receptor (GHR) mRNA in liver,
skeletal muscle and adipose tissue of different breeds of
pig. Animal Science 62: 555-559. 
Brameld, J. M., Atkinson, J. L., Saunders, J. C., Pell, J. M.,
Buttery, P. J. and Gilmour, R. S. 1996b. Effects of growth
hormone administration and dietary protein intake on
insulin-like growth factor I and growth hormone receptor
mRNA expression in porcine liver, skeletal muscle, and
adipose tissue. Journal of Animal Science 74: 1832-1841. 
Breier, B. H., Milsom, S. R., Blum, W. F., Schwander, J.,
Gallaher, B. W. and Gluckman, P. D. 1993. Insulin-like
growth factors and their binding proteins in plasma and
milk after growth hormone-stimulated galactopoiesis in
normally lactating women. Acta Endocrinologica  129:
427-435. 
Buonomo, F. C. and Klindt, J. 1993. Ontogeny of growth
hormone (GH), insulin-like growth factors (IGF-I and IGF-
II) and IGF binding protein-2 (IGFBP-2) in genetically lean
and obese swine. Domestic Animal Endocrinology 10: 257-265. 
Chung, C. S. and Etherton, T. D. 1986. Characterization of
porcine growth hormone (pGH) binding to porcine liver
microsomes: chronic administration of pGH induces pGH
binding. Endocrinology 119: 780-786. 
Clutter, A. C., Spicer, L. J., Woltmann, M. D., Grimes,
R. W., Hammond, J. M. and Buchanan, D. S. 1995. Plasma
growth hormone, insulin-like growth factor I, and insulin-
like growth factor binding proteins in pigs with divergent
genetic merit for postweaning average daily gain. Journal of
Animal Science 73: 1776-1783. 
Coleman, M. E., Russell, L. and Etherton, T. D. 1994.
Porcine somatotropin (pST) increases IGF-I mRNA
abundance in liver and subcutaneous adipose tissue but not
in skeletal muscle of growing pigs. Journal of Animal Science
72: 918-924. 
Combes, S., Louveau, I. and Bonneau, M. 1997. Moderate
food restriction affects skeletal muscle and liver growth
hormone receptors differently in pigs. Journal of Nutrition
127: 1944-1949. 
Duchamp, C., Burton, K. A., Herpin, P. and Dauncey, M. J.
1996. Perinatal ontogeny of porcine growth hormone
receptor gene expression is modulated by thyroid status.
European Journal of Endocrinology 134: 524-531. 
Elsaesser, F. and Drath, S. 1995. The potential of immuno-
neutralization of somatostatin for improving pig
performance. Livestock Production Science 42: 255-263. 
Etherton, T. D., Wiggins, J. P., Chung, C. S., Evock, C. M.,
Rebhun, J. F. and Walton, P. E. 1986. Stimulation of pig
growth performance by porcine growth hormone and
growth hormone-releasing factor. Journal of Animal Science
63: 1389-1399. 
Grant, A. L., Helferich, W. G., Kramer, S. A., Merkel, R. A.
and Bergen, W. G. 1991. Administration of growth
hormone to pigs alters the relative amount of insulin-like
growth factor-I mRNA in liver and skeletal muscle. Journal
of Endocrinology 130: 331-338. 
Hammond, A. C., Elsasser, T. H., Kunkle, W. E., Rumsey,
T. S., Williams, M. J. and Butts, W. T. 1990. Effects of winter
nutrition and summer pasture or a feedlot diet on plasma
insulin-like growth factor I (IGF-I) and the relationship
between circulating concentrations of IGF-I and thyroid
hormones in steers. Domestic Animal Endocrinology  7:
465-475. 
Hausman, G. J. 1989. The inﬂuence of insulin.
triiodothyronine (T3) and insulin-like growth factor-I (IGF-
1) on the differentiation of preadipocytes in serum-free
cultures of pig stromal-vascular cells. Journal of Animal
Science 67: 3136-3143. 
Hausman, G. J. 1999. The interaction of hydrocortisone and
thyroxine during fetal adipose tissue differentiation:430 Elsaesser, Pfafﬂ, Meyer, Serpek and Sauerwein
CCAAT enhancing binding protein expression and capillary
cytodifferentiation. Journal of Animal Science 77: 2088-2097. 
Herpin, P., LeDividich, J. and Amaral, N. 1993. Effect of
selection for lean tissue growth on body composition and
physiological state of the pig at birth. Journal of Animal
Science 71: 2645-2653. 
Johnson, J. L., Coffey, M. T., Esbenshade, K. L., Schricker,
B. R. and Pilkington, D. H. 1990. The effect of human
growth hormone-releasing factor or porcine somatotropin
on serum hormones and metabolites, growth performance
and carcass traits in swine. Journal of Animal Science 68:
3204-3211. 
Jorgensen, J. O., Pedersen, S. A., Laurberg, P., Weeke, J.,
Skakkebaek, N. E. and Christiansen, J. S. 1989. Effects of
growth hormone therapy on thyroid function of growth
hormone-deﬁcient adults with and without concomitant
thyroxine-substituted central hypothyroidism. Journal of
Clinical Endocrinology and Metabolism 69: 1127-1132. 
Klindt, J., Yen, J. T., Buonomo, F. C., Roberts, A. J. and
Wise, T. 1998. Growth, body compostition, and endocrine
responses to chronic administration of insulin-like growth
factor I and (or) porcine growth hormone in pigs. Journal of
Animal Science 76: 2368-2381. 
Lewis, A. J., Wester, T. J., Burrin, D. G. and Dauncey, M. J.
2000. Exogenous growth hormone induces somatotrophic
gene expression in neonatal liver and skeletal muscle.
American Journal of Physiology — Regulatory, Integrative and
Comparative Physiology 278: R838-R844. 
Marc, M., Parvizi, N., Ellendorff, F., Kallweit, E. and
Elsaesser, F. 2000. Plasma cortisol and ACTH concentrations
in the warmblood horse in response to a standardized
treadmill exercise test as physiological markers for
evaluation of training status. Journal of Animal Science 78:
1936-1946. 
Mersmann, H. J., Pond, W. G. and Yen, J. T. 1982. Plasma
glucose, insulin and lipids during growth of genetically
lean and obese swine. Growth 46: 189-198. 
Ono, Y., Solomon, M. B., Evock-Clover, C. M., Steele, N. C.
and Maruyama, K. 1995. Effects of porcine somatotropin
administration on porcine muscles located within different
regions of the body. Journal of Animal Science 73: 2282-2288. 
Ouali, A. and Talmant, A. 1990. Calpains and calpastin
distribution in bovine, porcine and ovine skeletal muscles.
Meat Science 28: 331-335. 
Owens, P. C., Gatford, K. L., Walton, P. E., Morley, W. and
Campbell, R. G. 1999. The relationship between
endogenous insulin-like growth factors and growth in pigs.
Journal of Animal Science 77: 2098-2103. 
Pfafﬂ, M., Meyer, H. H. and Sauerwein, H. 1998.
Quantiﬁcation of insulin-like growth factor-1 (IGF-1)
mRNA: development and validation of an internally
standardised competitive reverse transcription-polymerase
chain reaction. Experimental and Clinical Endocrinology and
Diabetes 106: 506-513. 
Sauerwein, H., Breier, B. H., Bass, J. J. and Gluckman,
P. D. 1991. Chronic treatment with bovine growth hormone
upregulates high-afﬁnity hepatic somatotropic receptors in
sheep. Acta Endocrinologica (Copenh) 124: 307-313. 
Schnoebelen-Combes, S., Louveau, I., Postel-Vinay, M.-C.
and Bonneau, M. 1996. Ontogeny of GH receptor and GH-
binding protein in the pig. Journal of Endocrinology 148:
249-255. 
Serpek, B., Elsaesser, F. and Meyer, H. H. D. 1993.
Development of an enzyme immunoassay for the
determination of porcine growth hormone in plasma.
Analytica Chimica Acta 275: 183-187. 
Sillence, M. N. and Etherton, T. D. 1987. Determination of
the temporal relationship between porcine growth
hormone, serum IGF-1 and cortisol concentrations in pigs.
Journal of Animal Science 64: 1019-1023. 
Torronteras, R., Gracia-Navarro, F. and Elsaesser, F. 1996.
Different effects of somatostatin on in vitro growth hormone
release in two porcine breeds with different growth rates.
Journal of Neuroendocrinology 8: 891-900. 
Van Kessel, A. G., Korchinski, R. S. and Laarveld, B. 1993.
Growth and serum thyroid hormone and insulin-like
growth factor I (IGF-I) responses to natural passive
immunization against somatostatin in the lamb. Canadian
Journal of Animal Science 73: 509-516. 
Walton, P. E. and Etherton, T. D. 1986. Stimulation of
lipogenesis by insulin in swine adipose tissue: antagonism
by porcine growth hormone. Journal of Animal Science  62:
1584-1595. 
Walton, P. E., Etherton, T. D. and Evock, C. M. 1986.
Antagonism of insulin action in cultured pig adipose tissue
by pituitary and recombinant porcine growth hormone:
potentiation by hydrocortisone. Endocrinology  118:
2577-2581. 
Wangsness, P. J., Acker, W. A., Burdette, J. H., Krabill, L. F.
and Vasilatos, R. 1981. Effect of fasting on hormones and
metabolites in plasma of fast-growing, lean and slow-
growing obese pigs. Journal of Animal Science 52: 69-74. 
Weiler, U., Claus, R., Schnoebelen-Combes, S. and
Louveau, I. 1998. Inﬂuence of age and genotype on
endocrine parameters and growth performance: a
comparative study in wild boars, Meishan and Large White
boars. Livestock Production Science 54: 21-31. 
Zenobi, P. D., Guler, H.-P., Zapf, J. and Froesch, E. R. 1988.
Insulin-like growth factors in the Göttinger miniature-pig.
Acta Endocrinologica 117: 343-352. 
(Received 20 July 2001—Accepted 1 November 2001)